
|Articles|September 18, 2014
- Melanoma (Issue 3)
- Volume 3
- Issue 1
Immunotherapy Combinations for the Treatment of Melanoma
Author(s)Mario Sznol, MD
Mario Sznol, MD, professor, Internal Medicine, Yale Cancer Center, discusses the potential for immunotherapy combinations for the treatment of melanoma.
Advertisement
Mario Sznol, MD, professor, Internal Medicine, Yale Cancer Center, discusses the potential for immunotherapy combinations for the treatment of melanoma.
Read about checkpoint strategies for the treatment of melanoma > >
Articles in this issue
about 11 years ago
Inducing an Immune Response With a Patient’s Tumorabout 11 years ago
Partnering T-VEC With a Targeted Agent for the Treatment of MelanomaAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Alpelisib/Fulvestrant Improves PFS in Post-CDK4/6 HR+/HER2- Breast Cancer
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Real-World Pola-R-CHP vs R-CHOP Effectiveness in Older DLBCL Patients
5









































